« Return to News | CROs/Service Providers

Thermo Fisher Expands Presence in India

Tuesday, December 9, 2008 11:50 AM

Global laboratory supply giant Thermo Fisher opened a new $17 million clinical services facility in Ahmedabad, India, giving the Waltham, Mass.-based company the largest Indian presence of any company in its industry, according to a company release.

The new 150,000-square-foot facility will support growing demand for biopharma services in the region and serve as a hub for packaging, distribution and logistics management of clinical trial supplies.

“With the added capacity now available to us with this new facility, we can offer our customers a higher level of technology, quality and expertise to facilitate clinical trials that serve the needs of both local and multi-national pharmaceutical companies,” said Thermo Fisher president and CEO Marijn Dekkers at the opening of the new facility.

Thermo Fisher first located in India in 2000 and has rapidly expanded its presence there through new facilities and acquisitions. Earlier this year, the company acquired the analytical technologies and environmental instrumentation divisions of Mumbai-based Chemito, India’s largest local supplier of analytical instruments for life sciences and environmental monitoring applications.

Thermo Fisher now has more than 20 facilities and 600 employees in India.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.